The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest ...

Alcoa (NYSE:AA – Free Report) had its price objective raised by HC Wainwright to $90.00 in a research note published on Tuesday morning,Stock Target Advisor reports. The firm currently has a buy ...

Shares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours trading after analysts at HC Wainwright reiterated their rating for the stock.

Fintel reports that on March 11, 2025, HC Wainwright & Co. downgraded their outlook for Checkpoint Therapeutics ...

Investment analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Cidara Therapeutics in a report issued on Monday, March 10th. HC Wainwright analyst E. Arce anticipates that the ...

H.C. Wainwright notes that Core Scientific’s (CORZ) stock “took a flyer” during trading yesterday on the news that its key HPC customer, ...

H.C. Wainwright initiated coverage of Inuvo (INUV) with a Buy rating and $2 price target Inuvo utilizes its proprietary IntentKey artificial ...

Plug Power (Nasdaq: PLUG). From a high north of $3, shares of the hydrogen pioneer have been cut roughly in half, falling as ...

H.C. Wainwright downgraded Chimerix (CMRX) to Neutral from Buy after the company agreed to be acquired for $8.55 per share in cash by Jazz Pharmaceuticals (JAZZ). The total consideration of ...

Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm: CANTA) today announced that Damian Marron, Interim CEO, will participate ...

Fintel reports that on March 5, 2025, HC Wainwright & Co. initiated coverage of Intellia Therapeutics (LSE:0JBU) with a Buy recommendation. There are 572 funds or institutions reporting positions ...

Damian Marron, interim CEO, will participate in a fireside chat moderated by Joe Pantginis, Managing Director, Equity Research at H.C. Wainwright & Co., LLC. March 27 at 08.00am EST (13.00pm CET).